29
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Glutathione (GSH) and the toxicity of oxidised low-density lipoprotein to human monocyte-macrophages

, , &
Pages 11-19 | Received 10 Jul 1997, Accepted 09 Jul 1998, Published online: 07 Jul 2009

References

  • Ball R.Y., Stowers E.C., Burton J.H., Cary N.R.B., Skepper J.N., Mitchinson M.J. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis 1995; 114: 45–54
  • Reid V.C., Mitchinson M.J. Toxicity of oxidised low-density lipoprotein towards mouse peritoneal macrophages in vitro. Atherosclerosis 1993; 98: 17–24
  • Marchant C.E., Law N.S., van der Veen C., Hardwick S.J., Carpenter K.L.H., Mitchinson M.J. Oxidized low-density lipoprotein is cytotoxic to human monocyte-macrophages, protection with lipophilic antioxidants. Federation of the European Biochemical Societies Letters 1995; 358: 175–178
  • Hardwick S.J., Hegyi L., Clare K., Law N.S., Carpenter K.L.H., Mitchinson M.J., Skepper J.N. Apoptosis in human monocyte-macrophages exposed to oxidized low-density lipoprotein. Journal of Pathology 1996; 179: 294–302
  • Hessler J.R., Morel D.W., Lewis L.J., Chisolm G.M. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 1983; 3: 215–222
  • Chisolm G.M., Ma G.P., Irwin K.C., Martin L.L., Gunderson K.G., Linberg L.F., Morel D.W., DiCorleto P.E. 7-β-Hydroperoxycholest-5-en-3-β-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidised human low-density-lipoprotein. Proceedings of the National Academy of Sciences, USA 1994; 91: 11452–11456
  • Kaneko T., Baba N., Matsuo M. Cytotoxicity of phosphatidylcholine hydroperoxides is exerted through decomposition of fatty-acid hydroperoxide moiety. Free Radical Biology and Medicine 1996; 21: 173–179
  • Zhou Q., Smith T.L., Kummerow F.A. Cytotoxicity of oxysterols on cultured smooth-muscle cells from human umbilical arteries. Proceedings of the Society for Experimental Biology and Medicine 1993; 202: 75–80
  • Hughes H., Mathews B., Lenz M.L., Guyton J.R. Cytotoxicity of oxidised LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arteriosclerosis and Thrombosis 1994; 14: 1177–1185
  • Clare K., Hardwick S.J., Carpenter K.L.H., Weeratunge N., Mitchinson M.J. Toxicity of oxysterols to human monocyte-macrophages. Atherosclerosis 1995; 118: 67–75
  • Müller K., Hardwick S.J., Marchant C.E., Law N.S., Waeg G., Esterbauer H., Carpenter K.L.H., Mitchinson M.J. Cytotoxic and chemotactic potencies of several aldehydic components of oxidised low-density lipoprotein for human monocyte-macrophages. Federation of the European Biochemical Society Letters 1996; 388: 165–168
  • Esterbauer H., Ramos P. Chemistry and pathophysiology of oxidation of LDL. Reviews in Physiology, Biochemistry and Pharmacology 1995; 127: 31–64
  • Allevi P., Anastasia M., Cajone F., Ciuffreda P., Sanvito A.M. Structural requirements of aldehyde production in lipid peroxidation for the activation of the heat-stress resistance genes in HeLa cells. Free Radical Biology and Medicine 1995; 18: 107–116
  • Zarkovic N., Tillian M.H., Schaur J., Waeg G., Jurin M., Esterbauer H. Inhibition of melanoma B16-F10 growth by lipid peroxidation product 4-hydroxynonenal. Cancer Biotherapy 1995; 10: 153–156
  • Brambilla G., Sciaba L., Faggin P., Maura A., Marinari U.M., Ferro M., Esterbauer H. Cytotoxicity, DNA fragmentation and sister-chromatid exchange in Chinese hamster ovary cells exposed to the lipid peroxidation product 4-HNE and homologous aldehydes. Mutation Research 1986; 171: 169–176
  • Meister A., Anderson M.E. Glutathione. Annual Reviews in Biochemistry 1983; 52: 711–760
  • Wendel A. Glutathione peroxidase. Enzymatic Basis of Detoxification, WB. Jakoby. Academic Press Inc., New York 1980; I: 333–348, In
  • Ketterer B., Coles B., Meyer D.J. The role of glutathione in detoxication. Environmental Health Perspectives 1983; 49: 59–69
  • De Torzano E.G.D., Castro J.A. Reaction of 4-hydroxynonenal with some thiol-containing radioprotective agents or their active metabolites. Free Radical Biology and Medicine 1994; 17: 605–607
  • Havel R.J., Eder H.A., Bragdon J.A. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. Journal of Clinical Investigation 1955; 24: 1345–1353
  • Lowry O.H., Rosebrough N.J., Farr A.C., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
  • Carpenter K.L.H., Wilkins G.M., Fussell B., Ballantine J.A., Taylor S.F., Mitchinson M.J., Leake D.S. Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper. Biochemical Journal 1994; 304: 625–633
  • Esterbauer H., Cheeseman K.H., Dianzani M.U., Poli G., Slater T.F. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by ADP-Fe2+ in rat liver microsomes. Biochemical Journal 1982; 208: 129–140
  • Lynch S.M., Frei B. Physiological thiol compounds exert pro- and antioxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. Biochimica et Biophysica Acta 1997; 1345: 215–221
  • Esterbauer H., Jurgens G., Quehenberger O., Koller E. Autoxidation of human LDL: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. Journal of Lipid Research 1987; 28: 495–509
  • Schaur R.J., Zollner H., Esterbauer H. Biological effects of aldehydes with particular attention to 4-hydroxynonenal and malonaldehyde. Membrane Lipid Oxidation, C. Vigo-Pelfrey. CRC Press, Boca RatonUSA 1991; III: 141–163, In
  • Tsai L., Sokoloski E.A. The reaction of 4-hydroxy-2-nonenal with Nα-acetyl-L-histidine. Free Radical Biology and Medicine 1995; 19: 39–44
  • Uchida K., Stadtman E.R. Quantitation of 4-hydroxynonenal protein adducts. Methods in Enzymology 1994; 233: 371–380
  • Szweda L.I., Uchida K., Tsai L., Stadtman E.R. Inactivation of glucose-6-phosphate-dehydrogenase by 4-hydroxy-2-nonenal-selective modification of an activesite lysine. Journal a Biological Chemistry 1993; 268: 3342–3347
  • Uchida K., Stadman E.R. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proceedings of the National Academy of Sciences, USA 1992; 89: 4544–4548
  • Siems W.G., Hapner S.J., van Kujik F.J.G.M. 4-Hydroxynonenal inhibits Na+-K+-ATPase. Free Radical Biology and Medicine 1996; 20: 215–223
  • Darley-Usmar V.M., Severn A., O'Leary V.J., Rogers M. Treatment of macrophages with oxidized low-density-lipoprotein increases their intracellular glutathione content. Biochemical Journal 1991; 278: 429–434
  • Cotoh N., Graham A., Niki E., Darley-Usmar V.M. Inhibition of glutathione synthesis increases the toxicity of oxidized low-density-lipoprotein to human monocytes and macrophages. Biochemical Journal 1993; 296: 151–154
  • Anderson M.E., Powrie F., Puri R.F., Meister A. Glutathione monoethyl ester: preparation, uptake by tissues, and conversion to glutathione. Archives of Biochemistry and Biophysics 1985; 239: 538–548
  • Hanna P.M., Mason R.P. Direct evidence for inhibition of free-radical formation from Cu(I) and hydrogen peroxide by glutathione and other potential ligands using the epr spin-trapping technique. Archives of Biochemistry and Biophysics 1992; 295: 205–213
  • Pichorner H., Metodiewa D., Winterbourn C.C. Generation of superoxide and tyrosine peroxide as a result of tyrosyl radical scavening by glutathione. Archives of Biochemistry and Biophysics 1995; 323: 429–437
  • Jocelyn P.C. The Occurrence, Chemical Properties, Metabolism and Biological Function of Thiols and Disulfides. Academic Press, New York 1972
  • Braesen J.H., Beisiegel U., Niendorf A. Probucol inhibits not only the progression of atherosclerotic disease but causes a different composition of atherosclerotic lesions in WHHL rabbit. Virchows Archives 1995; 426: 179–188
  • Wang J.M., Huang C.J., Chow C.K. Red-cell vitamin-E and oxidative damage—a dual role of reducing agents. Free Radical Research 1996; 24: 291–298

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.